Key facts
- It has raised $9.6M across 1 recorded rounds; the latest was Early Stage VC ($9.6M) in May 2025.
- NeutraNarc has filed 1 Form D with the SEC, most recently May 2025 ($9.6M sold to 45 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for NeutraNarc
Funding rounds
1 roundsAbout NeutraNarc
Provider of an eco-friendly drug disposal system intended to prevent drug misuse. The company offers products for quick, ethical destruction of medications and DEA-controlled substances, which are safe, secure, irretrievable, eco-friendly, fast-acting, ready-to-use, and designed for regulatory compliance for healthcare, the general public, and law enforcement, enabling users to safely and responsibly dispose of medications and bio-hazards.
- Sector
- Healthcare
- HQ
- Cincinnati, OH, United States
- Founded
- 2023
- Website
- neutranarc.com/
- Ownership
- Privately Held (backing)
NeutraNarc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeutraNarc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeutraNarc in its N-PORT filings yet. We sweep new filings monthly.